乳腺癌和怀孕的临床试验
总计88058个结果
-
A2A Pharmaceuticals Inc.招聘中
-
Merrimack PharmaceuticalsSanofi完全的
-
Institut Claudius Regaud主动,不招人无淋巴结受累且 < 或 = 30 mm 的三阴性乳腺癌法国
-
M.D. Anderson Cancer CenterNovartis; Puma Biotechnology, Inc.; Celcuity Inc招聘中
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia; Hospital... 和其他合作者完全的
-
Fudan University未知
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt Ltd招聘中
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., Ltd招聘中
-
Peter MacCallum Cancer Centre, Australia招聘中
-
Novartis Pharmaceuticals终止
-
Calithera Biosciences, Inc完全的
-
Veru Inc.撤销
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Stanford UniversityCalifornia Breast Cancer Research Program完全的沮丧 | 创伤后应激障碍 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | HER2/Neu 阴性 | 晚期乳腺癌 | 转移性乳腺癌 | 种系 BRCA1 基因突变 | 种系 BRCA2 基因突变美国
-
The Netherlands Cancer InstituteHoffmann-La Roche招聘中
-
National Taiwan University HospitalDebiopharm International SA; Ministry of Health and Welfare尚未招聘三阴性乳腺癌 | 绝经前乳腺癌
-
University of Milano BicoccaEISAI s.r.l.招聘中
-
Henrik DitzelNational Board of Health, Denmark; CytoVac A/S招聘中
-
Massachusetts General HospitalMerck Sharp & Dohme LLC主动,不招人
-
SanofiSOLTI Breast Cancer Research Group完全的
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.完全的
-
Cancer Institute and Hospital, Chinese Academy...未知
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)招聘中
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Agency for Healthcare Research and Quality (AHRQ)主动,不招人
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; ETOP IBCSG Partners Foundation完全的
-
Nuvation Bio Inc.终止胶质瘤 | 乳腺癌 | 胶质母细胞瘤 | 晚期乳腺癌 | 前列腺癌 | 转移性乳腺癌 | 复发性胶质母细胞瘤 | 乳腺癌 | 去势抵抗性前列腺癌 | 前列腺肿瘤 | 前列腺癌 | 前列腺癌 | 胶质瘤,恶性 | 乳腺癌 | 乳腺恶性肿瘤 | 晚期乳腺癌 | 转移性乳腺癌 | 乳腺肿瘤 | 去势抵抗性前列腺癌 | 乳腺癌 | 前列腺癌 | 去势抵抗性前列腺肿瘤 | 神经胶质细胞瘤 | 胶质瘤,混合美国
-
Mayo ClinicNational Cancer Institute (NCI)招聘中解剖学 I 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后 IIB 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 乳腺导管原位癌 | 乳腺小叶原位癌 | 浸润性乳腺癌 | 三阴性乳腺癌 | 乳腺纤维囊性变美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC未知IV 期乳腺癌 | 复发性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌 | III期乳腺癌美国
-
Memorial Sloan Kettering Cancer Center完全的乳腺癌 | 转移性乳腺癌 | 乳腺癌第四期 | 实体癌 | HER2 阴性乳腺癌 | MEK1基因突变 | MEK2基因突变美国
-
Coordinación de Investigación en Salud, Mexico招聘中
-
Technical University of MunichEli Lilly and Company招聘中